Breaking News

Evotec Chief Business Officer Steps Down

Following Matthias Evers’ departure, the responsibilities of the CBO function will be distributed across the other Management Board functions.

Author Image

By: Charlie Sternberg

Associate Editor

Evotec SE’s Chief Business Officer, Dr. Matthias Evers, has decided to step down to pursue opportunities outside of Evotec. He will depart the company effective October 1, 2024.   Dr. Evers, Chief Business Officer of Evotec SE, commented: “Thank you to my amazing colleagues across all of Evotec – the passion for medicines that matter is inspiring and the people at Evotec make all the difference. While I have chosen to pursue a new path, I wish Evotec with all colleagues long-term success which...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters